Tag: FDA social media

FDA social media

PhRMA, BIO, AdvaMed Tell FDA Social Media Guidance Is Lacking, Violates First Amendment

Oct. 6, 2104 – Although the FDA’s Office of Prescription Drug Promotion (OPDP) recently reopened the comment period for its two social media draft guidances, all three major industry trade associations – the Pharmaceutical Research and Manufacturers of America (PhRMA), the Biotechnology Industry Organization (BIO) and the Advanced Medical Technology Association (AdvaMed) – already had […]

Read more

FDA Social Media Draft Guidances Answer Some Questions, Raise Others

July 21, 2014 – Although the FDA has attempted to provide some clarity on its position regarding certain social media issues and practices, the agency’s recent draft guidance documents do not leave industry communicators with a crystal clear path and, indeed, “raise some important questions that communicators may have for their counsel,” according to Mark […]

Read more

CHC Press Release: Comment on Social Media Draft Guidance

April 9, 2014 — The Coalition for Healthcare Communication issued the following press release today regarding the CHC Social Media Comment it submitted yesterday on the FDA draft guidance issued in January. FOR IMMEDIATE RELEASE: CONTACT: John Kamp Executive Director Coalition for Healthcare Communication 703-801-4582 (mobile) jkamp@cohealthcom.org CHC Comment on Social Media Draft Guidance Calls […]

Read more

Coalition Seeks Input on FDA Online Promotion Guidance

Jan. 23, 2014 – The Coalition for Healthcare Communication would like to receive feedback from its members regarding the FDA social media draft guidance released Jan. 13: “Fulfilling Regulatory Requirements for Postmarketing Submissions of Interactive Promotional Media for Prescription Human and Animal Drugs and Biologics.” (See related article at http://www.cohealthcom.org/?p=2439.)The Coalition is creating a subcommittee […]

Read more

Kamp Column: Industry Must Embrace Internet and Social Media or Become Irrelevant in Many Health Conversations

By John Kamp, Executive Director, Coalition for Healthcare Communication June 29, 2011 — Yesterday I had the pleasure of moderating a lively panel discussion at the 2011 BIO annual meeting in D.C., titled: “Talking About Your Product in the New Age: Social Media and the Internet.” While every speaker recognized the regulatory uncertainty and complexity […]

Read more